Low sex drive affects at least one out of five women in the United States. A study presented at this year's American Psychiatric Association meeting found that bupropion hydrochloride sustained-release tablets may be an effective treatment for some women who suffer from hypoactive sexual desire disorder (HSDD). There is currently no approved drug treatment for low sex drive in women.
Researchers found that almost one-third of the women in the study responded with increases in the number of episodes of sexual arousal, sexual fantasy, and interest in engaging in sexual activity. Women included in the study were aged 23 to 65 and had experienced HSDD for an average of six years. Participants saw improvement as early as two weeks after beginning treatment.
No comments:
Post a Comment